Table 1.
Clinical parameters for patients who underwent curative resection with extended right hepatectomy (ERH) without portal vein embolization (PVE) or after PVE.
Parameter | ERH without PVE (n=123) |
ERH after PVE (n=87) |
P |
---|---|---|---|
Age, median (range), y | 56 (25–85) | 53 (33–77) | 0.13 |
Gender, male, no. (%) | 65 (52.8) | 60 (69) | 0.02 |
ASA score ≥3, no. (%) | 78 (63.4) | 71 (82) | 0.004 |
sFLR at presentation, median (IQR), % | - | 18.1 (14.1–22.7) | - |
sFLR before surgery, median (IQR), % | 27.5 (22.8–33.3) | 27.1 (21.5–34.2) | 0.94 |
Preoperative chemotherapy, no. (%) | 91 (74.0) | 76 (87) | 0.02 |
Number of tumors, median (range) | 3 (1–21) | 5 (1–21) | 0.0002 |
Maximum tumor size, median (range), mm | 30 (10–260) | 33 (5–190) | 0.82 |
Operation time, median (range), min | 170 (81–551) | 305 (85–745) | <0.0001 |
Blood loss, median (range), mL | 400 (40–2900) | 500 (50–3500) | 0.37 |
Transfusion, no. (%) | 30 (24.4) | 15 (17) | 0.34 |
Major complication, no. (%) | 27 (22.0) | 27 (31) | 0.14 |
Postoperative hepatic insufficiency, no. (%) | 18 (14.6) | 9 (10) | 0.48 |
90–day mortality, no. (%) | 5 (4.1) | 6 (7) | 0.37 |
ASA, American Society of Anesthesiologists; IQR, interquartile range; sFLR, standardized future liver remnant.